For people ages 1 month and up
Intervention
At the community-level, eligibility includes:
Inclusion Criteria:
- Location in Dosso, Tahoua, Maradi, Zinder, or Tillabéri regions
- Distinguishable from neighboring communities
- Verbal consent of community leader(s)
Exclusion criteria:
- Inaccessible or unsafe for study team
- "Quartier" designation on national census
At the individual-level, eligibility includes:
Inclusion criteria:
- Age 1-11 months
- Primary residence in a study community
- Verbal consent of caregiver/guardian for study participation
Exclusion criteria:
- Known allergy to macrolides
Population-based sample collections
At the community-level, eligibility includes:
Inclusion criteria:
- Location in study region
- Distinguishable from neighboring communities
- Verbal consent of community leader(s)
Exclusion criteria:
- Inaccessible or unsafe for study team
- Included in MORDOR trials
- Not randomly selected
At the individual-level, eligibility includes:
Inclusion criteria:
- Age 1-59 months or 7-12 years or caregiver/guardian of a child eligible for treatment
- Primary residence in a study community selected for sample collections
- Verbal consent of caregiver/guardian for study participation
Exclusion criteria:
- Not on list of randomly selected participants from the census